Literature DB >> 11832654

Role of p38(MAPK) in cell volume regulation of perfused rat liver.

S vom Dahl1, F Schliess, D Graf, D Häussinger.   

Abstract

In perfused rat liver, hypoosmotic exposure (225 mosmol/L) leads to a volume-regulatory decrease by release of K(+), Cl(-) and HCO(3)(-) through Ba(2+)-, DIDS- and quinidine-sensitive ion channels. The underlying signal transduction mechanisms, however, are unknown. As hypoosmotic hepatocyte swelling leads to a rapid activation of extracellular signal regulated kinases (Erks) and of p38(MAPK), the role of mitogen-activated protein kinases (MAPK) and PI-3-kinase in mediating the RVD in perfused rat liver was studied. The presence of the MEK inhibitor PD 098 059, which blocks the hypoosmotic activation of Erks, had no effect on the extent and time course of cell volume regulatory K(+) efflux. However, inhibitors of p38(MAPK) such as SB 203 580 and PD 169 316, but not their inactive analogue SB 202 474, significantly delayed and diminished the volume-regulatory K(+) efflux. Accordingly, in presence of these p38(MAPK) inhibitors, the hepatocytes remained in a more swollen state after completion of RVD. Inhibition of hypoosmotic Erk activation by pertussis or cholera toxin, erbstatin or genistein had no effect on RVD by hypoosmolarity. Likewise, neither inhibition of PI-3-kinase by wortmannin or LY 294 002 nor inhibition of S 6 phosphorylation by rapamycin nor protein kinase inhibition by H-7, H-89 or KT 5823 led to a significant change of RVD upon hypoosmolarity. The amount and time course of K(+) release by oxidative stress upon addition of t-BOOH or H(2)O(2) remained unaffected by inhibition of p38(MAPK) by SB 203 580, suggesting a specific inhibition of RVD-dependent K(+) release by this inhibitor. The findings suggest that swelling-induced activation of p38(MAPK), but not of Erks and PI-3-kinase, is involved in RVD in liver, whereas p38(MAPK) is apparently not involved in the net K(+) release induced by oxidative stress. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11832654     DOI: 10.1159/000047815

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  7 in total

1.  Epidermal growth factor receptor is activated by hyposmolarity and is an early signal modulating osmolyte efflux pathways in Swiss 3T3 fibroblasts.

Authors:  Rodrigo Franco; Ruth Lezama; Benito Ordaz; Herminia Pasantes-Morales
Journal:  Pflugers Arch       Date:  2004-01-16       Impact factor: 3.657

2.  Activation of integrins by urea in perfused rat liver.

Authors:  Roland Reinehr; Holger Gohlke; Annika Sommerfeld; Stephan Vom Dahl; Dieter Häussinger
Journal:  J Biol Chem       Date:  2010-07-19       Impact factor: 5.157

3.  Volume regulation following hyposmotic shock in isolated turbot (Scophthalmus maximus) hepatocytes.

Authors:  Hélène Ollivier; Karine Pichavant; Eneour Puill-Stephan; Stella Roy; Patrick Calvès; Liliane Nonnotte; Guy Nonnotte
Journal:  J Comp Physiol B       Date:  2006-01-04       Impact factor: 2.200

4.  Differential dependence of regulatory volume decrease behavior in rabbit corneal epithelial cells on MAPK superfamily activation.

Authors:  Zan Pan; José E Capó-Aponte; Fan Zhang; Zheng Wang; Kathryn S Pokorny; Peter S Reinach
Journal:  Exp Eye Res       Date:  2007-02-11       Impact factor: 3.467

5.  Swelling-activated chloride and potassium conductance in primary cultures of mouse proximal tubules. Implication of KCNE1 protein.

Authors:  H Barrière; I Rubera; R Belfodil; M Tauc; N Tonnerieux; C Poujeol; J Barhanin; P Poujeol
Journal:  J Membr Biol       Date:  2003-06-01       Impact factor: 1.843

Review 6.  Calcium modulates osmosensitive taurine efflux in HeLa cells.

Authors:  Pablo Olivero; Andrés Stutzin
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

7.  Differential introgression and the maintenance of species boundaries in an advanced generation avian hybrid zone.

Authors:  Jennifer Walsh; W Gregory Shriver; Brian J Olsen; Adrienne I Kovach
Journal:  BMC Evol Biol       Date:  2016-03-22       Impact factor: 3.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.